Clinical Trial Update: Bipolar II Depression: Lithium, SSRI, or the Combination [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating lithium, an SSRI, or their combination for bipolar II depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Ii Disorder
• Major Depressive Disorder

Drugs mentioned

• Lithium (Lithium carbonate)
• Lithium + SSRI
• Selective serotonin reuptake inhibitor (selective serotonin reuptake inhibitor)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bipolar Disorder, Depression | Phase 3 | Status: COMPLETED